146 related articles for article (PubMed ID: 19845000)
1. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
[TBL] [Abstract][Full Text] [Related]
2. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
[TBL] [Abstract][Full Text] [Related]
3. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C
Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286
[TBL] [Abstract][Full Text] [Related]
4. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Hu MT; Scherfler C; Khan NL; Hajnal JV; Lees AJ; Quinn N; Wood NW; Brooks DJ
Mov Disord; 2006 Mar; 21(3):299-305. PubMed ID: 16211589
[TBL] [Abstract][Full Text] [Related]
5. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Scherfler C; Khan NL; Pavese N; Eunson L; Graham E; Lees AJ; Quinn NP; Wood NW; Brooks DJ; Piccini PP
Brain; 2004 Jun; 127(Pt 6):1332-42. PubMed ID: 15090472
[TBL] [Abstract][Full Text] [Related]
6. In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.
Pavese N; Moore RY; Scherfler C; Khan NL; Hotton G; Quinn NP; Bhatia KP; Wood NW; Brooks DJ; Lees AJ; Piccini P
Exp Neurol; 2010 Mar; 222(1):120-4. PubMed ID: 20043906
[TBL] [Abstract][Full Text] [Related]
7. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Khan NL; Scherfler C; Graham E; Bhatia KP; Quinn N; Lees AJ; Brooks DJ; Wood NW; Piccini P
Neurology; 2005 Jan; 64(1):134-6. PubMed ID: 15642918
[TBL] [Abstract][Full Text] [Related]
10. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
[TBL] [Abstract][Full Text] [Related]
11. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
12. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.
Ribeiro MJ; Thobois S; Lohmann E; du Montcel ST; Lesage S; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Broussolle E; Brice A; Remy P;
J Nucl Med; 2009 Aug; 50(8):1244-50. PubMed ID: 19617340
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.
Hagenah JM; König IR; Becker B; Hilker R; Kasten M; Hedrich K; Pramstaller PP; Klein C; Seidel G
J Neurol; 2007 Oct; 254(10):1407-13. PubMed ID: 17934880
[TBL] [Abstract][Full Text] [Related]
14. [18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Pal PK; Leung J; Hedrich K; Samii A; Lieberman A; Nausieda PA; Calne DB; Breakefield XO; Klein C; Stoessl AJ
Mov Disord; 2002 Jul; 17(4):789-94. PubMed ID: 12210877
[TBL] [Abstract][Full Text] [Related]
15. Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.
Pavese N; Rivero-Bosch M; Lewis SJ; Whone AL; Brooks DJ
Neuroimage; 2011 Jun; 56(3):1463-8. PubMed ID: 21396455
[TBL] [Abstract][Full Text] [Related]
16. [Clinical utility of (18)F-DOPA-PET in movement disorders. A systematic review].
Puñal-Riobóo J; Serena-Puig A; Varela-Lema L; Alvarez-Páez AM; Ruano-Ravina A
Rev Esp Med Nucl; 2009; 28(3):106-13. PubMed ID: 19558950
[TBL] [Abstract][Full Text] [Related]
17. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Brück A; Aalto S; Nurmi E; Vahlberg T; Bergman J; Rinne JO
Mov Disord; 2006 Jul; 21(7):958-63. PubMed ID: 16550545
[TBL] [Abstract][Full Text] [Related]
18. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
[TBL] [Abstract][Full Text] [Related]
19. Brain parenchyma sonography detects preclinical parkinsonism.
Walter U; Klein C; Hilker R; Benecke R; Pramstaller PP; Dressler D
Mov Disord; 2004 Dec; 19(12):1445-9. PubMed ID: 15390070
[TBL] [Abstract][Full Text] [Related]
20. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
